Obtaining valid consent for gene editing requires more than a signed form; it demands transparent communication, independent oversight, and culturally appropriate engagement that recognize scientific uncertainty and intergenerational effects. The National Academies of Sciences, Engineering, and Medicine recommends layered governance and rigorous review for human genome editing research, while the World Health Organization emphasizes public engagement, registries, and global coordination to ensure that consent processes are meaningful and accountable.
Principles of informed consent
Core informed consent elements include clear disclosure of the purpose, procedures, potential benefits, foreseeable and unforeseeable risks, alternatives, and the limits of current knowledge. Ezekiel J. Emanuel at the University of Pennsylvania has argued that ethical research requires scientific validity, social value, and a favorable risk–benefit ratio, all of which must be explained to participants so consent is truly informed. For gene editing, this explanation must explicitly address long-term uncertainty such as off-target effects, heritability when germline cells are involved, and the possibility of unknown health consequences emerging years later. Consent documentation should include provisions for long-term follow-up, data sharing policies, and the participant’s right to withdraw, recognizing that withdrawal may be limited in some contexts once biological changes are made.
Special contexts and community engagement
Context matters. Germline editing and interventions affecting embryos present unique consent challenges because future persons cannot be asked for their permission; policy guidance from the Nuffield Council on Bioethics stresses that societal deliberation and distributive justice considerations are necessary where intergenerational effects are possible. When interventions affect whole communities or environments, such as potential gene drives intended to alter wild populations, consent cannot be reduced to individual signatures. The World Health Organization advises multi-stakeholder consultation and community-level engagement to respect local values, territorial rights, and ecological stewardship. Indigenous and marginalized communities may require collective decision-making mechanisms that reflect cultural norms and historical experiences of exploitation.
Consequences of inadequate consent include loss of trust, exploitation of vulnerable participants, and social harms such as stigmatization or genetic discrimination. The 2018 case involving He Jiankui highlighted global concern when robust oversight and transparent consent were absent; ensuing international critique reinforced calls from the National Academies and the World Health Organization for stronger governance and public accountability. Practically, ethically sound consent for gene editing therefore combines individualized, comprehensible information delivered by trained communicators with independent ethical review boards, community consultation, mechanisms for ongoing monitoring, and clear plans for benefit sharing and harm mitigation.
Implementing these measures requires institutional commitment and resources. Research institutions and regulatory bodies should adopt standardized consent templates informed by best-practice guidance from the World Health Organization and the National Academies of Sciences, Engineering, and Medicine, while funding patient education and long-term follow-up. Such an approach aligns respect for individual autonomy with collective responsibilities to future people, local communities, and the environment.